First Line Gefitinib by FDG-PET Metabolic Response

Clinical trial NCT01510990 · UNKNOWN

Trial details

NCT number: NCT01510990
Sponsor: Asan Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2012-04-01
Primary completion: 2013-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.